期刊文献+

补肾养血安胎汤联合地屈孕酮对先兆流产患者TT3水平血清E2水平及继续妊娠率的影响 被引量:18

原文传递
导出
摘要 目的探讨补肾养血安胎汤联合地屈孕酮对先兆流产患者总三碘甲状腺激素(TT_(3))水平、血清雌二醇(E_(2))水平及继续妊娠率的影响。方法选取2018年11月—2019年11月宁波市中医院收治的110例先兆流产患者随机分为研究组和对照组各55例,对照组给予地屈孕酮治疗,研究组在前者基础上给予补肾养血安胎汤治疗。观察并对比两组治疗总有效率、治疗前后甲状腺功能[TT_(3)、总四碘甲状腺激素(TT_(4))、促甲状腺激素(TSH)]水平、治疗前后患者雌激素水平[孕酮(P)、E_(2)、人绒毛膜促性腺激素(hCG)]、治疗前后细胞因子[白细胞介素-2(IL-2)、白细胞介素-10(IL-10)]水平以及患者继续妊娠率、临床症状缓解时间。结果研究组治疗总有效率及继续妊娠率分别为96.36%、92.73%明显高于对照组的78.18%、70.91%,差异有统计学意义(P<0.05)。治疗前两组患者血清TT_(3)、TT_(4)、TSH、P、E_(2)、hCG、IL-2、IL-10水平比较差异无统计学意义(P>0.05);治疗后两组患者血清TT_(3)、TT_(4)、P、E_(2)、hCG、IL-10水平较治疗前均明显升高且研究组明显高于对照组,血清TSH、IL-2水平较治疗前明显降低且研究组明显低于对照组,差异均有统计学意义(P<0.05)。治疗后研究组临床症状缓解时间较对照组明显缩短,差异有统计学意义(P<0.05)。结论补肾养血安胎汤联合地屈孕酮治疗先兆流产效果较好,可有效改善甲状腺功能,降低炎性水平,促进雌激素分泌,提高先兆流产患者继续妊娠率,缩短临床症状缓解时间,具有一定临床推广价值。
作者 田敏 陈嫣
出处 《中国妇幼保健》 CAS 2022年第5期864-867,共4页 Maternal and Child Health Care of China
  • 相关文献

参考文献9

二级参考文献105

  • 1Fatemi HM.The luteal phase after 3 decades of IVF:what do we know?[J].Reprod Biomed Online,2009,19 Suppl 4:4331.
  • 2van der Linden M,Buckingham K,Farquhar C,et al.Luteal phase support for assisted reproduction cycles[J].Cochrane Database Syst Rev,2015(7):CD009154.DOI:10.1002/14651858.CD009154.pub3.
  • 3Yildiz GA,Sukur YE,Ates C,et al.The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles:a randomized clinical trial[J].Eur J Obstet Gynecol Reprod Biol,2014,182:66-70.DOI:10.1016/j.ejogrb.2014.08.026.
  • 4Kung HF,Chen MJ,Guua HF,et al.Luteal phase support with decapeptyl improves pregnancy outcomes in intracytoplasmic sperm injection with higher basal follicle-stimulating hormone or lower mature oocytes[J].J Chin Med Assoc,2014,77(10):524-530.DOI:10.1016/j.jcma.2014.07.001.
  • 5Kyrou D,Kolibianakis EM,Fatemi HM,et al.Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles:a systematic review and meta-analysis[J].Hum Reprod Update,2011,17(6):734-740.DOI:10.1093/ humupd/dmr029.
  • 6Balasch J,Martinez F,Jove I,et al.Inadvertent gonadotrophin- releasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in-vitro fertilization patients[J].Hum Reprod,1993,8(7):1148-1151.
  • 7van der Linden M,Buckingham K,Farquhar C,et al.Luteal phase support for assisted reproduction cycles[J].Cochrane Database Syst Rev,2011(10):CD009154.DOI:10.1002/ l4651858.CD009154.pub2.
  • 8Tesarik J,Hazout A,Mendoza-Tesarik R,et al.Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist-and antagonist-treated ovarian stimulation cycles[J].Hum Reprod,2006,21(10):2572-2579.
  • 9Ruan HC,Zhu XM,Luo Q,et al.Ovarian stimulation with GnRH agonist,but not GnRH antagonist,partially restores the expression of endometrial integrin beta3 and leukaemia- inhibitory factor and improves uterine receptivity in mice[J].Hum Reprod,2006,21(10):2521-2529.
  • 10Wong KH,Simon JA.In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis[J].Am J Obstet Gynecol,2004,190(1):44-49.

共引文献217

同被引文献218

引证文献18

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部